The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy people understand what to change before disease develops.

Some thought he was crazy.

That idea became InsideTracker, the company he founded 17 years ago, which brings together blood biomarkers, genetic information and wearable data to give people personalised recommendations for improving their health.

In this conversation, Dr Blander traces the scientific journey that took him from the Weizmann Institute to MIT and eventually to founding InsideTracker. He explains what he learned from some of the early breakthroughs in longevity research, why collecting more health data is not enough if people do not act on it, and why he believes behaviour change may now be one of the biggest challenges in extending healthy life.

We also discuss his recent decision to step back from his operational role at InsideTracker and what he describes as his “second career”: taking personalised, preventative health beyond the longevity community and making it relevant to a much wider population.

Guest Bio

Dr Gil Blander is the founder of InsideTracker, a personalised health and longevity platform that combines blood biomarkers, DNA and wearable data to generate individualised health recommendations.

He trained as a scientist at the Weizmann Institute, where he worked with Professor Moshe Oren on p53 and cancer biology, before moving to MIT to join Professor Leonard Guarente’s laboratory during an important period in the study of genes associated with ageing and longevity.

After 17 years leading InsideTracker, Dr Blander recently stepped back from his operational role to focus on bringing personalised and preventative health to a much broader population.

About Dr Gil Blander

Principal: Healthspan Strategies Advisors and Founder and CEO of Stealth Health Tech startup

* Instagram: Founder of @insidetracker

* Instagram: Host of @beyond_healthspan_podcast

* LinkedIn: linkedin.com/in/gilblander

* Company: insidetracker.com

* Longevity by Design: info.insidetracker.com/longevitybydesign

Episode Chapters

* 00:00 Welcome and Guest Introduction

* 03:07 Why Data Alone Does Not Change Health

* 05:02 Different People Need Different Motivation

* 07:01 The Scientific Roots at Weizmann

* 11:50 Inside MIT’s Early Longevity Research

* 13:24 Leaving Academia for Industry

* 16:04 The Idea Behind InsideTracker

* 19:25 How InsideTracker Works

* 20:35 Why Blood, DNA and Wearables Work Better Together

* 26:14 Why Behaviour Change May Be the Real Frontier

* 27:48 Taking Longevity Beyond the Longevity Bubble

* 30:43 What Actually Makes Healthy Habits Stick

* 34:58 What Real-World Data Can Teach Us

* 40:29 Stepping Back and Starting a “Second Career”

* 42:05 Longevity Hype, Science and the Limits of What We Know

* 44:27 Rapid Fire

* 47:20 Final Takeaways

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(37)

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Longevity medicine has created a strange new kind of patient: the healthy person convinced something must be wrong.A wearable flags poor recovery. One test says your body is ageing faster than it shou...

20 Syys 1h

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

At 16, Chris Mirabile was lying in a hospital bed the night before brain surgery, wondering whether he would wake up the next morning. Years later, as he was building NOVOS, he lost his mother to panc...

13 Syys 1h 14min

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Recorded at HLTH Europe in Amsterdam, Part Two of our special series looks at four very different ways technology could help healthcare move earlier, become more personalised and make better use of th...

6 Syys 57min

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

What happens when technology stops simply tracking our health and starts helping us understand what to do about it?Recorded at HLTH Europe in Amsterdam, this episode of Beyond Longevity features three...

30 Elo 42min

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

What if a vaccine could help the immune system clear senescent “zombie” cells — damaged cells linked to ageing, chronic inflammation and age-related disease?In this episode of Beyond Longevity, Daphna...

23 Elo 56min

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at...

16 Elo 1h 6min

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Elo 59min